These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12125243)

  • 21. [Estimation of the possibilities of using unified chemotherapy regimens in new cases of pulmonary tuberculosis in old-age children and adolescents].
    Gubkina MF; Ershova NG
    Probl Tuberk Bolezn Legk; 2009; (1):33-6. PubMed ID: 19256010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Very high frequency electromagnetic irradiation in multimodal treatment of patients with disseminated infiltrative pulmonary tuberculosis].
    Iakovleva LP; Lineva ZE; Mozhokina GN
    Probl Tuberk; 2001; (2):11-2. PubMed ID: 11490454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Surveillance of adverse effects of antituberculous therapy upon the liver (author's transl)].
    Estay S; Armas Merino R; Busel I; Baier E; Wolff C; Jabsa Z
    Rev Med Chil; 1981 Mar; 109(3):212-20. PubMed ID: 7280406
    [No Abstract]   [Full Text] [Related]  

  • 24. [Results of use of surfactant in complex therapy of patients with destructive pulmonary tuberculosis].
    Lovacheva OV; Erokhin VV; Chernichenko NV; Evgushchenko GV; Lepekha LN; Rozenberg OA
    Probl Tuberk Bolezn Legk; 2006; (10):12-7. PubMed ID: 17139825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Emoxipine correction of lipid peroxidation disorders in patients with osteoarthrosis deformans].
    Shved NI; Belozetskaia-Smiian SI
    Vrach Delo; 1991 Oct; (10):101-3. PubMed ID: 1803728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Side effects of antituberculous drugs observed within six months after admission. Tuberculosis Research Committee, Ryoken (author's transl)].
    Kekkaku; 1975 Jun; 50(6):161-7. PubMed ID: 1185917
    [No Abstract]   [Full Text] [Related]  

  • 27. [Differential pathogenetic therapy in the complex treatment of patients with destructive pulmonary tuberculosis].
    Molotkov VN; Ivaniuta OM; Bystritskaia VI; Mel'nik VN
    Probl Tuberk; 1982 Feb; (2):45-8. PubMed ID: 7063479
    [No Abstract]   [Full Text] [Related]  

  • 28. [Relation between drug intolerance and immunologic disorders in patients with pulmonary tuberculosis].
    Lomako MN; Abramovskaia AK; Batian AN; Batian ON
    Probl Tuberk; 1991; (5):51-4. PubMed ID: 1924244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Incidence and pattern of recurrent side effects in persons with different haptoglobin phenotypes during chemotherapy of pulmonary tuberculosis].
    Ubaĭdullaev AM; Tashpulatova FK; Kazakov KS
    Probl Tuberk; 1998; (4):23-4. PubMed ID: 9771032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis.
    Park IN; Hong SB; Oh YM; Kim MN; Lim CM; Lee SD; Koh Y; Kim WS; Kim DS; Kim WD; Shim TS
    J Antimicrob Chemother; 2006 Sep; 58(3):701-4. PubMed ID: 16857689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy of treatment for pulmonary tuberculosis with multidrug mycobacterial resistance].
    Mishin VIu; Chukanov VI; Vasil'eva IA
    Probl Tuberk; 2002; (12):18-23. PubMed ID: 12611329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Incidence of adverse reactions to chemotherapy and their types in adolescents with tuberculosis].
    Panova LV; Ovsiankina ES
    Probl Tuberk; 2003; (1):28-30. PubMed ID: 12652980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The use of antioxidants for the correction of coronary risk factors in patients with myocardial ischemia].
    Derbeneva SA; Pogozheva AV; Vasil'ev AV; Akol'zina SE; Lysikova SL
    Vopr Pitan; 2003; 72(4):17-20. PubMed ID: 12968298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of tuberculosis in persons with mental diseases].
    Shcherbatiuk AS; Sabanov AI
    Probl Tuberk; 1980 Jan; (1):48-51. PubMed ID: 7367424
    [No Abstract]   [Full Text] [Related]  

  • 36. [The use of antioxidants and antihypoxants in tuberculosis (a review of the literature)].
    Skakun NP
    Vrach Delo; 1991 Mar; (3):52-6. PubMed ID: 2042350
    [No Abstract]   [Full Text] [Related]  

  • 37. [Enzymatic parameters of the liver function in patients with active pulmonary tuberculosis and adverse reactions to chemotherapeutic drugs].
    Bondarenko VP
    Probl Tuberk; 1979 Nov; (11):37-40. PubMed ID: 530967
    [No Abstract]   [Full Text] [Related]  

  • 38. [A study on the clinical efficacy of a combination regimen with levofloxacin and capreomycin in the treatment of multi-drug resistant pulmonary tuberculosis].
    Chen QL; Chen L; Yin JJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Aug; 26(8):454-7. PubMed ID: 14505519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New-onset pulmonary tuberculosis patients with schizophrenia: course and efficiency of treatment].
    Mishin VIu; Shevchuk EIu; Tsygankov BD; Losev LV
    Probl Tuberk Bolezn Legk; 2008; (6):6-10. PubMed ID: 18710046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Vitamin B complex metabolism in children with tuberculosis during combination vitamin therapy].
    Kirpichev MP
    Probl Tuberk; 1979 May; (5):48-53. PubMed ID: 314114
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.